WS12.3 Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis severe patients with the F508del/minimal function genotype

Authors :: P. Medio
M. d'Ippolito
Giovanni Taccetti
S. Buonaurio
F. De Gregorio
Vito Terlizzi
Michela Francalanci
Paola Iacotucci
Donatello Salvatore
Giovanni Marsicovetere
L. Ferrillo
Vincenzo Carnovale
Carmela Colangelo
Michele D'Andria
Nicola Ferrara
Source :: Journal of Cystic Fibrosis. 20:S23-S24
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
medicine.medical_specialty
business.industry
medicine.disease
Cystic fibrosis
Gastroenterology
Ivacaftor
Internal medicine
Pediatrics, Perinatology and Child Health
Genotype
medicine
Tezacaftor
business
medicine.drug

Tools